The 3830 lead is the only FDA-approved lead for providing conduction system pacing in the United States, including both His-bundle pacing (HBP) and left bundle branch area pacing (LBBAP).
Conduction system pacing (CSP) is approved to provide physicians an alternative to right ventricular pacing in a single or dual chamber pacing system in bradycardia patients.
The first and only FDA-approved MR Conditional lead for left bundle branch area pacing, when paired with Medtronic MRI SureScan systems.
3830 use in the left bundle branch area is supported by real-world evidence encompassing 20k+ patients.1
3830 has a novel lumenless design and fixed helix, allowing for increased helix stability at implant relative to extendable/retractable helix leads.1,2
The fatigue performance of the 3830 lead in a left bundle branch area position compares to performance in the RV (98% reliability, 95% CI) based on simulated 10-year testing.3
SelectSecure 3830 Left Bundle Branch Area Pacing Safety and Efficacy Utilizing RWE. Medtronic data on file.
Riley WF, Zachary LW. Introduction to Mechanics of Materials. Hoboken, NJ: Wiley; 1989.
Zou J, Chen K, Liu X, et al. Clinical use conditions of lead deployment and simulated lead fracture rate in left bundle branch area pacing. J Cardiovasc Electrophysiol. Published online February 4, 2023.